All posts tagged "OTC Derivatives"
-
542Capital RegulationHKMA Published Revised SPM on Non-Cleared OTC Derivatives
Banks currently in scope of the margin requirements and risk mitigation standards have until 1 September 2021 to comply wth the revised supervisory policy manual.
September 15, 2020 -
561Capital RegulationRBI Issues Draft Rules on Variation Margin Exchange
The rules are applicable to India-regulated financial firms, IFSC banking units, and FPIs with non-cleared derivatives exceeding 500bn rupees.
September 8, 2020 -
611Capital RegulationSGX to Offer Free Analytics to Facilitate UMR Preparation
Through a partnership with Cassini Systems, SGX will provide market participants the analysis needed to understand how they can reduce the UMR cost burden.
August 27, 2020 -
682FeatureISDA Calls for Global Alignment in UPI, UTI Implementation
ISDA is urging the FSB to "intensify monitoring and coordination of jurisdictional alignment" to the global UTI, UPI and CDE recommendations.
August 26, 2020 -
692Hong Kong
HKMA Aligns Benchmark Reform Guidance for Banks with BCBS
HKMA's new guidance covers issues with benchmark reform relating to the definition of capital, market risk, counterparty credit risk, liquidity and operational risk.
July 27, 2020 -
625Capital RegulationBCBS Finalises Targeted Revisions to CVA Risk Framework
Completion of the final adjustments to the CVA framework represents the conclusion of outstanding policy work related to the Basel III framework.
July 8, 2020 -
889Capital RegulationS. Korea Advances OTC Derivatives Reforms
Cabinet-approved legislative revisions will introduce an OTC derivatives reporting requirement, a licensing system for trade repositories, and penalties for circumventing margin rules.
July 3, 2020 -
452Hong KongHKMA, SFC Publish Final List of FSPs Under Clearing Obligation
The HKMA and SFC will remove one entity that no longer conducts OTC derivatives business as its institutional services are now being provided by BofA Securities Inc, a new FSP.
June 25, 2020 -
389FeatureSFC to Narrow Scope of OTC Derivatives Licensing Regime
The OTC derivatives licensing regime will not capture corporate treasury activities of non-financial groups, portfolio compression services, and certain portfolio management activities.
June 10, 2020 -
482Australia & NZESMA Clarifies Transparency Rules, Position Limits for Non-EU Venues
ESMA has clarified its application of post-trade transparency requirements and the position limits regime to third-country trading venues.
June 4, 2020
